Granules India Limited Paracetamol Export Data — India (DGFT 2022–2026)

Name: Granules India Limited Paracetamol Export Records India — #4 Exporter, 224 Shipments, $11.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Paracetamol

India Pharmaceutical Trade Intelligence

$357.3M870 Suppliers170 CountriesHS 30049069

ExportsIndia → UNITED KINGDOM15.4%India → AUSTRALIA9.0%

ImportsMEXICO → India$686.3K GERMANY → India$483.4K

#1 Supplier: ADCOCK INGRAM #1 Buyer: ADCOCK INGRAM

Granules India Limited — Paracetamol Exporter #4 | $11.2M Trade Value | TransData Nexus | TransData Nexus

Granules India Limited — Paracetamol Exporter Profile

Indian Pharmaceutical Exporter · #4 for Paracetamol · $11.2M export value · DGFT Verified

Granules India Limited is the #4 Indian exporter of Paracetamol with $11.2M in export value and 224 verified shipments. Granules India Limited holds a 3.1% market share in Paracetamol exports across 21 countries. The company exports 20 pharmaceutical products worth $412.3M across 9 therapeutic categories.

Granules India Limited — Paracetamol Export Profile: Buyers & Destinations

Granules India Limited Paracetamol export treemap — buyers and destination countries | TransData Nexus

Where Does Granules India Limited Export Paracetamol?

Country	Value	Shipments	Share
DENMARK	$4.2M	123	17.4%
GERMANY	$3.1M	67	12.6%
IRELAND	$2.6M	58	10.8%
AUSTRALIA	$2.6M	57	10.7%

Who Are the Top Buyers of Paracetamol from Granules India Limited?

Buyer	Country	Value	Orders
ORIFARM SUPPLY A/S	DENMARK	$3.2M	96
MERCKLE GMBH	GERMANY	$2.5M	50
HALEON AUSTRALIA PTY LTD	AUSTRALIA	$1.7M	38
GLAXOSMITHKLINE DUNGARVAN LTD	IRELAND	$1.5M	31
MODERN PHARMA TRADING COMPANY	EGYPT	$1.3M	27
TEVA PHARMA BV	NETHERLANDS	$1.2M	39
HALEON EG LIMITED	EGYPT	$1.1M	21
CLONMEL HEALTHCARE	IRELAND	$1.0M	26
GULF PHARMACEUTICAL INDUSTRIES	UNITED ARAB EMIRATES	$850.0K	17
ORIFARM SUPPLY A S ENERGIVEJ	DENMARK	$819.2K	22

Granules India Limited supplies Paracetamol to 72 buyers globally. The largest buyer is ORIFARM SUPPLY A/S (DENMARK), followed by MERCKLE GMBH (GERMANY) and HALEON AUSTRALIA PTY LTD (AUSTRALIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Paracetamol Formulations Does Granules India Limited Export?

Product Description / Formulation	Value	Shipments
COMPRESSO PAP 77P (PARACETAMOL GRANULES	$1.3M	25
Compresso PAP 90CPC(Paracetamol/Acetamin	$803.8K	17
COMPRESSO PAP 77P PARACETAMOL GRANULESDC 77	$600.0K	12
COMPRESSO PAP 77P (PARACETAMOL GRANULESDC 77)	$600.0K	12
PANADOL FD GRANULATE (PARACETAMOL GRANUL	$500.0K	10
Compresso PAP 77P (Paracetamol Granules	$432.9K	9
COMPRESSO PAP 90 CPC (PARACETAMOL/ACETAM	$414.1K	9
PANADOLFD GRANULATE PARACETAMOL DC GRANULES	$400.0K	8
PANADOL FD GRANULATE(PARACETAMOL GRANULES DC 74.23)	$350.0K	7
PARACETAMOL TEVA 500 MG TABLETS(OP1000)	$335.5K	7

Granules India Limited exports 304 distinct Paracetamol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is COMPRESSO PAP 77P (PARACETAMOL GRANULES with 25 shipments worth $1.3M.

How Does Granules India Limited Compare to Nearest Paracetamol Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	INDOCO REMEDIES LIMITED	$21.6M	432	9	$50.0K
6	ZENTIVA PRIVATE LIMITED	$12.3M	321	5	$38.4K
4	GRANULES INDIA LIMITED ★	$11.2M	224	21	$50.0K
5	SRI KRISHNA PHARMACEUTICALS LIMITED	$10.6M	212	14	$50.0K
7	MEDREICH LIMITED	$8.1M	241	10	$33.8K

Granules India Limited ranks #4 among 870 Indian Paracetamol exporters. Average shipment value of $50.0K compared to the market average of $180.9K. The closest competitors by value are INDOCO REMEDIES LIMITED and ZENTIVA PRIVATE LIMITED.

Which Indian Ports Ship Paracetamol Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	4,107	27.4%
BANGALORE ICD (INWFD6)	1,125	7.5%
JNPT	959	6.4%
JNPT/ NHAVA SHEVA SEA	763	5.1%
SAHAR AIR CARGO ACC (INBOM4)	717	4.8%
AHEMDABAD ICD (INSBI6)	620	4.1%
MUNDRA SEA (INMUN1)	480	3.2%
CHENNAI SEA (INMAA1)	410	2.7%

Geopolitical & Trade Policy Impact on Granules India Limited's Paracetamol Exports

Granules India's export operations are influenced by various geopolitical factors. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, compelling maritime carriers to reroute via the Cape of Good Hope. This has resulted in increased lead times and freight costs, posing challenges for time-sensitive pharmaceutical shipments. To mitigate these risks, Granules India is leveraging its multi-site manufacturing capabilities and strategic inventory positioning. (pharmaceuticalcommerce.com)

The U.S.-China trade tensions have created opportunities for Indian pharmaceutical exporters like Granules India, as global buyers seek to diversify their supply chains. However, compliance with evolving U.S. pharmaceutical import policies remains crucial. In the European Union, the implementation of the Falsified Medicines Directive necessitates stringent serialization and traceability measures. Granules India's proactive approach to regulatory compliance positions it favorably to navigate these complexities and maintain its export momentum.

Granules India Limited — Regulatory Compliance & Quality Standards

Regulatory compliance is paramount for Granules India, given its extensive export operations. The company's Gagillapur facility in Telangana received a warning letter from the U.S. Food and Drug Administration (FDA) in February 2025, following an inspection that identified issues related to equipment maintenance and contamination control. In response, Granules India implemented comprehensive corrective and preventive actions, including engaging independent consultants and enhancing cleaning protocols. The company has been providing regular updates to the FDA and is prepared for re-inspection to demonstrate compliance. (moneycontrol.com)

Conversely, Granules India's U.S.-based packaging facility in Virginia successfully cleared an FDA inspection in December 2025 with zero observations, reflecting the company's commitment to quality and regulatory excellence. (pharma.economictimes.indiatimes.com)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Paracetamol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Granules India Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 600 individual customs records matching Granules India Limited exporting Paracetamol, covering 304 formulations to 31 countries via 72 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 170+ countries, 2,197+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Paracetamol

Paracetamol

Granules India Limited — Paracetamol Exporter Profile

Granules India Limited — Paracetamol Export Profile: Buyers & Destinations

Where Does Granules India Limited Export Paracetamol?

Who Are the Top Buyers of Paracetamol from Granules India Limited?

What Is India's Total Paracetamol Export Value and How Much Does Granules India Limited Contribute?

What Is the Average Shipment Value for Granules India Limited's Paracetamol Exports?

How Does Granules India Limited Compare to Other Indian Paracetamol Exporters?

What Paracetamol Formulations Does Granules India Limited Export?

Regulatory Requirements: Exporting Paracetamol to Key Markets

Germany — BfArM/EMA

How Does Granules India Limited Compare to Nearest Paracetamol Exporters?

Which Indian Ports Ship Paracetamol Exports?

What Other Analgesics & Antipyretics Products Does Granules India Limited Export?

Paracetamol — Export Intelligence Video

Geopolitical & Trade Policy Impact on Granules India Limited's Paracetamol Exports

Granules India Limited — Regulatory Compliance & Quality Standards

About Granules India Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Paracetamol Export Data from Granules India Limited

Paracetamol Stats

Company Overview

Top Products by Granules India Limited

Related Analysis

Need Detailed Export Data?

Data Source